A detailed history of Exodus Point Capital Management, LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 554,958 shares of TXG stock, worth $8.14 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
554,958
Previous 289,211 91.89%
Holding current value
$8.14 Million
Previous $5.63 Million 122.77%
% of portfolio
0.08%
Previous 0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.71 - $23.49 $4.17 Million - $6.24 Million
265,747 Added 91.89%
554,958 $12.5 Million
Q2 2024

Aug 13, 2024

BUY
$19.45 - $37.37 $2.4 Million - $4.61 Million
123,479 Added 74.51%
289,211 $5.63 Million
Q1 2024

May 14, 2024

BUY
$36.08 - $54.3 $5.98 Million - $9 Million
165,732 New
165,732 $6.22 Million
Q2 2023

Aug 10, 2023

BUY
$50.96 - $58.72 $5.49 Million - $6.33 Million
107,718 New
107,718 $6.02 Million
Q4 2022

Feb 13, 2023

BUY
$24.4 - $41.3 $957,700 - $1.62 Million
39,250 New
39,250 $1.43 Million
Q2 2022

Aug 19, 2022

SELL
$36.95 - $82.41 $722,852 - $1.61 Million
-19,563 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$55.7 - $145.79 $832,269 - $2.18 Million
14,942 Added 323.35%
19,563 $1.49 Million
Q4 2021

Feb 11, 2022

BUY
$135.05 - $182.59 $624,066 - $843,748
4,621 New
4,621 $688,000
Q3 2021

Nov 15, 2021

SELL
$145.58 - $192.14 $795,740 - $1.05 Million
-5,466 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$134.22 - $202.37 $733,646 - $1.11 Million
5,466 New
5,466 $1.07 Million
Q1 2021

May 17, 2021

SELL
$140.25 - $196.86 $3.13 Million - $4.4 Million
-22,326 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$126.47 - $163.7 $3.95 Million - $5.12 Million
-31,255 Reduced 58.33%
22,326 $3.16 Million
Q3 2020

Nov 16, 2020

BUY
$87.44 - $125.0 $4.69 Million - $6.7 Million
53,581 New
53,581 $6.68 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.